This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Oxitec Recognised By Prestigious Frost And Sullivan Award For Its Pioneering System Of Pest Control

The award comes just months after Oxitec reported success in trials controlling a population of the dengue mosquito in Brazil, and follows further research development in its agricultural products for the Mediterranean fruit fly, Olive fly and Pink Bollworm moth.

"It's particularly pleasing to have affirmation today not only of the innovative nature of our technology, but also that leading industry experts have recognised the significant environmental benefits we can offer," Mr Parry added. "Our products are uniquely targeted to the pest species in question: in short, it is an approach which is safe, effective and sustainable."

About Oxitec Ltd.

Oxitec is a pioneer in controlling insects that spread disease and damage crops. Its products build upon the use of the Sterile Insect technique (SIT), an effective, species-specific and environmentally friendly method of controlling harmful and damaging insects. Oxitec first products are for the control of Aedes aegypti, the mosquito species primarily responsible for transmitting dengue fever and Mediterranean fruit fly, one of the world's most damaging agricultural pests. Further information available at, FB Oxitec, Twitter @Oxitec

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Their "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure. Their Integrated Value Proposition provides support their clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,776.43 +304.06 1.85%
S&P 500 1,987.05 +35.69 1.83%
NASDAQ 4,781.2640 +73.4890 1.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs